TANG CAPITAL MANAGEMENT, LLC 13D and 13G filings for Aurinia Pharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-03-04 5:04 pm Purchase | 2025-02-28 | 13D | Aurinia Pharmaceuticals Inc. AUPH | TANG CAPITAL MANAGEMENT, LLC | 10,029,500 7.300% | 2,800,000 (+38.73%) | Filing |
| 2024-09-12 4:10 pm Purchase | 2024-09-06 | 13D | Aurinia Pharmaceuticals Inc. AUPH | TANG CAPITAL MANAGEMENT, LLC | 7,229,500 5.100% | 7,229,500 (New Position) | Filing |